We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Medica Corporation

Medica markets and sells in vitro diagnostic analyzers, such as clinical chemistry analyzers, electrolyte analyzers, ... read more Featured Products: More products

Download Mobile App




Distribution Agreement Signed for Assistant Digital Cell Imaging System

By LabMedica International staff writers
Posted on 19 May 2014
HORIBA Medical (Montpellier, France) and Medica Corporation (Bedford, MA, USA) have entered into a nonexclusive agreement for the worldwide distribution of the EasyCell assistant digital hematology cell imaging system for use in hospitals and clinical laboratories worldwide.

The EasyCell assistant automatically locates white cells on a blood smear and preclassifies them on a display, grouped by cell type. More...
The system displays images of red cells and platelets for performance of red cell morphology and platelet estimates. The EasyCell also features Remote Viewing Software for sharing of cell images throughout the hospital and Competency Review Software for training of medical technologists in the hematology laboratory.

Olivier Pou, corporate marketing director, HORIBA Medical commented on the agreement with the Medica Corp., "The EasyCell assistant is an important addition to our hematology product range and is a good match with our five-part differential hematology instrument portfolio. The addition of the Medica EasyCell assistant to our product offering makes it possible for HORIBA Medical to provide a complete range of advanced technology to our hematology customers, worldwide."

Medica Corp. uses its proprietary technology to manufacture easy-to-use, low-cost, blood testing analyzers. The analyzers are easy to operate and service and can be used routinely by personnel with a wide range of skill levels in hospital laboratories.

HORIBA Medical provides an extensive and complete line of hematology and clinical chemistry analyzers (including reagents) for in vitro medical diagnostics.

Related Links:

HORIBA Medical
Medica Corporation



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hemodynamic System Monitor
OptoMonitor
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.